DSN LINK STABLECARRIER WAVE LOCKORBITAL INDEX HOTSIGNAL CLOCK SYNCLOW NOISE FLOORFRAME BUFFER ONLINE
Loading
1 article
Novartis drops $3B on SNV4818, a PI3Kα inhibitor claiming pan-mutant coverageâwhere alpelisibâs toxicity and modest efficacy leave room for a rival.